Roundview Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $231K | Sell |
2,670
-160
| -6% | -$15.3K | 0.01% | 324 |
|
|
2025
Q4 | $272K | Buy |
2,830
+610
| +27% | +$59.3K | 0.02% | 297 |
|
|
2025
Q3 | $211K | Buy |
+2,220
| New | +$204K | 0.01% | 322 |
|
|
2023
Q4 | – | Sell |
-6,228
| Closed | -$488K | – | 316 |
|
|
2023
Q3 | $488K | Sell |
6,228
-159
| -2% | -$13.3K | 0.05% | 240 |
|
|
2023
Q2 | $563K | Sell |
6,387
-539
| -8% | -$46.4K | 0.05% | 235 |
|
|
2023
Q1 | $558K | Sell |
6,926
-574
| -8% | -$46.8K | 0.06% | 233 |
|
|
2022
Q4 | $583K | Sell |
7,500
-5,255
| -41% | -$426K | 0.07% | 222 |
|
|
2022
Q3 | $1.03M | Buy |
12,755
+823
| +7% | +$74K | 0.13% | 156 |
|
|
2022
Q2 | $1.07M | Sell |
11,932
-980
| -8% | -$99.3K | 0.13% | 156 |
|
|
2022
Q1 | $1.43M | Sell |
12,912
-587
| -4% | -$62K | 0.15% | 147 |
|
|
2021
Q4 | $1.4M | Sell |
13,499
-2,979
| -18% | -$345K | 0.14% | 160 |
|
|
2021
Q3 | $2.06M | Buy |
16,478
+835
| +5% | +$108K | 0.23% | 114 |
|
|
2021
Q2 | $1.94M | Buy |
15,643
+1,398
| +10% | +$176K | 0.22% | 123 |
|
|
2021
Q1 | $1.68M | Buy |
14,245
+311
| +2% | +$36.5K | 0.21% | 124 |
|
|
2020
Q4 | $1.63M | Sell |
13,934
-827
| -6% | -$91K | 0.22% | 110 |
|
|
2020
Q3 | $1.53M | Sell |
14,761
-1,318
| -8% | -$132K | 0.24% | 101 |
|
|
2020
Q2 | $1.47M | Buy |
16,079
+537
| +3% | +$51.5K | 0.25% | 105 |
|
|
2020
Q1 | $1.4M | Buy |
15,542
+1,147
| +8% | +$122K | 0.3% | 97 |
|
|
2019
Q4 | $1.63M | Buy |
14,395
+5,176
| +56% | +$568K | 0.31% | 97 |
|
|
2019
Q3 | $1M | Buy |
9,219
+790
| +9% | +$82.4K | 0.22% | 127 |
|
|
2019
Q2 | $821K | Buy |
8,429
+2,009
| +31% | +$183K | 0.18% | 137 |
|
|
2019
Q1 | $585K | Buy |
6,420
+3,258
| +103% | +$292K | 0.14% | 154 |
|
|
2018
Q4 | $288K | Buy |
3,162
+1,097
| +53% | +$103K | 0.08% | 177 |
|
|
2018
Q3 | $203K | Buy |
+2,065
| New | +$191K | 0.05% | 214 |
|
|
2018
Q1 | – | Sell |
-7,076
| Closed | -$571K | – | 225 |
|
|
2017
Q4 | $571K | Buy |
7,076
+25
| +0.4% | +$2K | 0.15% | 148 |
|
|
2017
Q3 | $548K | Buy |
7,051
+150
| +2% | +$12.5K | 0.16% | 151 |
|
|
2017
Q2 | $612K | Buy |
6,901
+785
| +13% | +$66.2K | 0.18% | 142 |
|
|
2017
Q1 | $493K | Buy |
6,116
+2,125
| +53% | +$166K | 0.15% | 146 |
|
|
2016
Q4 | $284K | Buy |
+3,991
| New | +$314K | 0.09% | 178 |
|
Other funds holding MDT
VCM
VPM
Roundview Capital's MDT Position: Q1 2026 in Review
Roundview Capital reduced its Medtronic (MDT) stake by 5.7% in Q1 2026, selling an estimated $15.3K and leaving 2,670 shares worth $231K. The position accounts for 0.01% of the portfolio, ranked #324.
Roundview Capital first reported a position in MDT in Q4 2016 and has held it in 29 quarters since. The position peaked at $2.06M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Roundview Capital held 2,670 shares of Medtronic worth $231K as of Q1 2026.
- Roundview Capital sold 160 Medtronic shares in Q1 2026, an estimated $15.3K.
- Medtronic made up 0.01% of Roundview Capital's portfolio in Q1 2026, its #324 holding.
- Roundview Capital first reported a position in Medtronic in Q4 2016 and has held it in 29 quarters since.
- Roundview Capital's Medtronic position peaked at $2.06M in Q3 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Roundview Capital's 13F filing for Q1 2026, filed 8 May 2026.